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Research
NF-Y coassociates with FOS at promoters, enhancers,
repetitive elements, and inactive chromatin regions,
and is stereo-positioned with growth-controlling
transcription factors
Joseph D. Fleming,1 Giulio Pavesi,2 Paolo Benatti,3 Carol Imbriano,3 Roberto Mantovani,2
and Kevin Struhl1,4
1Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA;
2Dipartimento di BioScienze, Universita` degli Studi di Milano, 20133 Milano, Italy; 3Dipartimento di Scienze della Vita, Universita`
di Modena e Reggio Emilia, 41125 Modena, Italy
NF-Y, a trimeric transcription factor (TF) composed of two histone-like subunits (NF-YB and NF-YC) and a sequence-
specific subunit (NF-YA), binds to the CCAAT motif, a common promoter element. Genome-wide mapping reveals
5000–15,000 NF-Y binding sites depending on the cell type, with the NF-YA and NF-YB subunits binding asymmetrically
with respect to the CCAAT motif. Despite being characterized as a proximal promoter TF, only 25% of NF-Y sites map to
promoters. A comparable number of NF-Y sites are located at enhancers, many of which are tissue specific, and nearly
half of the NF-Y sites are in select subclasses of HERV LTR repeats. Unlike most TFs, NF-Y can access its target DNA motif
in inactive (nonmodified) or polycomb-repressed chromatin domains. Unexpectedly, NF-Y extensively colocalizes with
FOS in all genomic contexts, and this often occurs in the absence of JUN and the AP-1 motif. NF-Y also coassociates with
a select cluster of growth-controlling and oncogenic TFs, consistent with the abundance of CCAAT motifs in the pro-
moters of genes overexpressed in cancer. Interestingly, NF-Y and several growth-controlling TFs bind in a stereo-specific
manner, suggesting a mechanism for cooperative action at promoters and enhancers. Our results indicate that NF-Y is not
merely a commonly used proximal promoter TF, but rather performs a more diverse set of biological functions, many of
which are likely to involve coassociation with FOS.
[Supplemental material is available for this article.]
Transcriptional regulatory proteins and the RNApolymerase II (Pol
II)machinery recruit chromatin-modifying activities to their target
loci, thereby determining the genomic pattern of histone modifi-
cations and nucleosome occupancy. Activator proteins, function-
ing combinatorially at distal enhancers and in proximity to core
promoters, recruit nucleosome remodeling and histone acetylase
complexes, thereby generating nucleosome-depleted regions that
nevertheless have peaks of histone acetylation. The Pol II machinery
recruits H3K4 histone methylases near the core promoter, and
upon transcriptional elongation recruits H3K36 and H3K79 histone
methylases to active coding regions. Although lesswell defined, other
DNA-binding proteins and nascent RNA can recruit H3K27 or H3K9
methylases to other genomic regions, resulting in heterochromatic
silencing by polycomb complexes (PcG) or HP1, respectively.
As a consequence of the above and other mechanistic re-
lationships between TFs and chromatin-modifying activities, the
genome-wide pattern of histone modifications and nucleosome
occupancy can be used to classify promoters, enhancers, in-
sulators, and distinct types of heterochromatic regions in a given
cell type under a given physiological condition. Using chromatin
immunoprecipitation (ChIP), formaldehyde-assisted isolation of
regulatory elements (FAIRE), and DNase I hypersensitivity tech-
niques coupled to massively parallel DNA sequencing, such clas-
sification of functional genomic regions has been done in several
cell lines in the context of ENCODE (The ENCODE Project Con-
sortium 2004, 2007, 2011, 2012). In addition, ENCODE has per-
formed genome-wide mapping of binding sites for;80 TFs (at the
time ofwriting),most notably in the leukemia cell line K562. These
genome-wide maps provide an invaluable resource for uncovering
new functional aspects of individual TFs.
NF-Y (also known as CBF, CP1) is a heterotrimeric, DNA-
binding TF that is conserved in all eukaryotes (Romier et al. 2003).
NF-Y binds specifically to the CCAAT motif (Sinha et al. 1995; Bi
et al. 1997) that is frequently found in eukaryotic promoters
(Suzuki et al. 2001; Marino-Ramirez et al. 2004). The NF-YB and
NF-YC subunits (protein products of NFYB and NFYC) contain
histone-fold domains (HFDs) structurally related to H2B and H2A,
respectively (Baxevanis et al. 1995), which mediate formation of
a stable histone-like heterodimer (Romier et al. 2003). NF-YA
(protein product of NFYA) binds to this heterodimer, such that the
resulting heterotrimeric complex can bind specifically to the
CCAAT motif (Sinha et al. 1995). NF-YA contains the sequence-
specific CCAAT recognition domain, and NF-YB and NF-YC also
contact DNA through their HFDs (Kim et al. 1996; Sinha et al.
1996; Zemzoumi et al. 1999). All bases of the core pentanucleotide
are critical for NF-Y binding, with immediate flanking sequences
on both ends also being important for efficient DNA binding in
vitro (Hooft van Huijsduijnen et al. 1987; Kim et al. 1990) and in
vivo (Testa et al. 2005; Ceribelli et al. 2006, 2008).
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At many promoters, the CCAAT motif is highly positioned
;80 bp upstream of the transcriptional start site (TSS), in either
orientation, suggesting that its location is important for gene ex-
pression. In essentially all promoters tested, mutation of the CCAAT
motif reduces or eliminates transcriptional activity (Dolfini et al.
2009). In addition, functional inactivation of NF-Y subunits or the
use of a dominant-negative NF-YA mutant indicates that NF-Y
binding is important for the pattern of histone modifications at
promoters (for review, see Dolfini et al. 2012). Interestingly, bio-
informatic studies comparing gene expression patterns in tumors
vs. normal tissues indicate that NF-Y sites are highly enriched in
promoters of genes overexpressed in tumors (Rhodes et al. 2005;
Sinha et al. 2008; Goodarzi et al. 2009), particularly in the most
aggressive cohorts. The importance of NF-Y is further underscored
by the early embryonic lethality of an NF-YA mouse knockout
model due to defects in cell proliferation and extensive apoptosis
(Bhattacharya et al. 2003).
Here we describe the genome-wide analysis of NF-Y binding
in three tumor cell lines. Using data generated by ENCODE, we
analyze the bound loci with respect to chromatin states and
binding by 78 chromatin-associating factors. Our results uncover
many new and unexpected aspects of NF-Y biology.
Results and Discussion
Unbiased genome-wide identification of NF-Y binding sites
We performed ChIP with anti-NF-YA and anti-NF-YB antibodies in
three cell types (K562, GM12878, and HeLa S3) followed by deep
DNA sequencing. Antibodies (Dolfini et al. 2009)were validated by
Western blot and IP-WB, showing that NF-YA and NF-YB are spe-
cifically recognized (Supplemental Fig. 1A,B). Immunoprecipitated
DNA was validated on known NF-Y targets (Supplemental Fig.
1C,D) and the reproducibility between biological replicates was
high (Pearson correlations: >0.8).
Using a stringent cut-off (P-value < 109), we identify 12655,
7932, and 5457 NF-YB binding sites and 4726, 289, and 3726
NF-YA binding sites in K562, GM12878, and HeLa S3 cells, re-
spectively (Fig. 1A). Applying the de novo motif discovery tool
MEME to NF-YB peaks in K562 cells, we identify an NF-Y bind-
ing motif (Fig. 1B) that corresponds well to the motif derived
from ChIP-chip experiments (Dolfini et al. 2009). These high-
confidence binding sites, 83% of which have at least one CCAAT
motif within each site (with a mean of 1.7 motifs per site), will be
used for subsequent bioinformatic analyses. At lower stringency,
we identify 14,772 (P < 107) and 18,523 (P < 105) NF-YB sites in
K562, 81% and 77% of which, respectively, have CCAAT motifs.
NF-YB sites with relatively high P-values in the range from 105
to 107 contain CCAAT motifs at a rate of ;60%, whereas the
genomic background is ;5% for similarly sized regions (Supple-
mental Fig. 2A). Based on these observations and a peak satura-
tion analysis (Supplemental Fig. 2B), we estimate that there are an
additional ;4000 low-affinity NF-Y binding sites in the genome
of K562 cells.
The apparently higher number of NF-YB sites with respect to
NF-YA sites could be due to target loci bound only byNF-YB. In this
regard, in nuclei, NF-YB is more abundant than NF-YA, and NF-YB
is present in certain post-mitotic cells whereas NF-YA is not
detected (Dolfini et al. 2012). However, the NF-YA and NF-YB data
sets are highly correlated (Pearson correlation ;0.7) (Fig. 1C), and
quantitative PCR analysis of individual sites reveal threefold
higher enrichments for NF-YB than for NF-YA. Furthermore,
analysis of 21 NF-YB sites that appear to lack NF-YA show low
occupancy of NF-YB, such that an NF-YA peak was below the
detection limit (Supplemental Fig. 3A,B). These results indicate
that the NF-YB antibody is more ‘‘immuno-efficient’’ than the
NF-YA antibody, and that there are few, if any, genomic sites that
are bound by NF-YB, but not NF-YA. For this reason, we will use
the NF-YB data set to define NF-Y binding sites in subsequent
analyses.
Approximately 39% of NF-Y sites are occupied in at least two
cell types, whereas the remaining are cell-type specific (Fig. 1D). In
accord with this observation, examination of 14 NF-Y target genes
identified previously in different cell lines (Ceribelli et al. 2008)
revealed that 13 are bound in K562 and eight are bound inHela S3.
We validated the cell-type specificity of a small number of these
loci by ChIP-qPCR (Fig. 1E).
Asymmetric binding of NF-YA and NF-YB to the CCAATmotif
Linking the high-resolution positioning data of NF-Y subunits to
the CCAAT motif, we confirm that NF-YA binds directly over the
CCAAT sequence (Fig. 2A). Interestingly, the NF-Y complex is asym-
metric, with NF-YB binding ;15 bp downstream from the CCAAT
motif, as defined by the CCAATstrand (Fig. 2A). This asymmetry
fits extremely well with the available biochemical knowledge
of NF-Y/DNA contacts (Dolfini et al. 2009) and with the crystal
structure of trimer interactions with DNA (Romier et al. 2003;
Nardini et al. 2013).
NF-Y targets cell signaling, DNA repair, cell-cycle, metabolic,
and gene expression genes
GREAT gene ontology analysis of NF-Y bound loci from K562,
GM12878, and HeLa S3 reveals a strong enrichment of genes in-
volved in cell-signaling pathways (ITGA2B, MAPK12, MAPK13),
cell cycle (G2/M checkpoints, regulation of DNA replication), DNA
repair (homologous recombination and base excision), and me-
tabolism (cholesterol biosynthesis, polyamines) (Supplemental
Fig. 4A,B). The connection to the cell cycle and metabolism are in
line with previous findings, and further stress the central role of
NF-Y in growth-controlling decisions.
In addition, just below our fold-enrichment cutoff, we found
a preponderance of GO terms associated with gene expression, in
multiple cell lines, that were highly significant. Upon further anal-
ysis, it was apparent that NF-Y significantly targeted genes involved
in transcription, mRNA splicing, mRNA editing, mRNA 39-end
processing, and mRNA transport. Included is a large and diverse set
of TFs, including the NF-Y genes themselves, members of the tran-
scriptional machinery, and coactivators and corepressors (Supple-
mental Fig. 5A,B; Supplemental Data Tables 10,11,12). Thus, NF-Y
appears to be a regulator of gene expression regulators.
In a separate analysis (IPA, Ingenuity) of signaling pathways,
we found that NF-Y preferentially associates with genes involved
in the interrelated TP53 (protein product of TP53, also known as
p53) and TNF-related apoptosis-inducing ligand (TRAIL) pathways
(Supplemental Fig. 5C,D). This observation reinforces the notion
of a direct and indirect NF-Y/TP53 interplay, with opposing func-
tional consequences depending on the TP53 status of the cell, i.e.,
proliferation or apoptosis (Imbriano et al. 2012). In addition, it is
consistent with anecdotal evidence about the role of NF-Y in ap-
optosis (Morachis et al. 2010; Hughes et al. 2011), which helps
explain the phenotypes of NF-YA overexpression and inactivation
experiments (Gatta and Mantovani 2011).
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NF-Y binds to a diverse set of genomic features including
nongenic regions
We annotated the NF-Y bound regions in K562 to RefSeq genes,
TSSs, maps of histone modifications and nucleosome-depleted
regions, and RNA levels. Unexpectedly,;25% of the NF-Y binding
sites are not situated near RefSeq promoters, or the following types
of genic regions: lncRNAs (Khalil et al. 2009); miRBASE (Kozomara
and Griffiths-Jones 2011); UCSC RNA genes (Fujita et al. 2011);
NONCODE (He et al. 2008); loci bound by Pol II or Pol III (Moqtaderi
Figure 1. ChIP-seq of two components of the NF-Y complex in three cell types. (A) MACS peak analysis indicating peak numbers, mean peak lengths,
and standard deviations at three different P-value thresholds for NF-YA andNF-YB ChIP-seq data sets in GM12878, HeLa S3, and K562. (B) Identification of
the NF-Y DNA-binding site motif de novo from 12,655 K562NF-YB peaks depicted as a sequence logo (Schneider and Stephens 1990). (C ) Scatter plots of
NF-YA, NF-YB, and input read counts at NF-YA or NF-YB sites in K562 showing correlation between data sets. (Blue shading) Correlation amongst NF-YA
and NF-YB. (Orange shading) NF-YA or NF-YB correlation to input. (D) Venn diagrams depicting the overlap between NF-YB peak populations in
GM12878, HeLa S3, and K562. Integers represent peak numbers called at the 109 P-value threshold. The percentages of peaks with CCAAT motifs are
indicated (%). (E) ChIP-qPCR validation of NF-YB peaks unique to each cell type. (Error bars) Standard deviation of three biological replicates. ‘‘Pos. Ctrls’’
are loci known to be bound by NF-Y. ‘‘Neg Ctrls’’ are loci known to be devoid of NF-Y. Data represents a fold over background measurement compared
with a non-NF-Y bound region (‘‘GAPDH up’’). (Solid and striped bars) ChIPs performed with NF-YB specific antibody and nonspecific rabbit IgG,
respectively.
Genome-wide analysis of NF-Y
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et al. 2010). These sites are not false positives, because the vast
majority (88%) have CCAAT motifs, and 46% of them are pre-
sent in at least one other cell type. Based on the patterns of colo-
calized histone modifications and Pol II, NF-Y-bound regions in
K562 and HeLa S3 reproducibly partition into 20 clusters that can
be grouped into fivemajor classes: promoter, enhancer, gene body,
PcG repressed, and LTR/nonmodified-chromatin. As discussed
below, these results indicate that NF-Y binding is prevalent in
tissue-specific enhancers and specific types of repetitive sequences,
in addition to proximal promoters, where
NF-Y has traditionally been observed.
Only a minority of NF-Y binding sites
are located at proximal promoter
regions
Although NF-Y is typically described as
a factor that binds to proximal promoter
regions, only 22% of NF-Y sites are lo-
cated within 1 kbp upstream of a RefSeq
TSS (Fig. 2B; Supplemental Fig. 6). A simi-
lar analysis shows ;30% of NF-Y sites are
located within chromatin states marked
by histone modifications characteristic of
promoters (Fig. 2C). This is consistent
with our previous analysis of 2% of the
human genome (Ceribelli et al. 2008). For
such proximal promoter binding sites, a
frequency distribution plot of peak sum-
mits indicates that NF-Y is highly posi-
tioned upstream of the TSS at 40 to
100 bp (Fig. 2D), in line with the posi-
tion of the CCAAT motif at TSSs (Fig. 2E),
in agreement with previously published
observations (Dolfini et al. 2009). Though
NF-YA and NF-YB bind asymmetrically to
the CCAAT motif, the orientation with
respect to the TSS is largely irrelevant for
transcription, as only a small difference
in the frequency of CCAAT and its com-
plement ATTGG are noticed on the same
strand (Fig. 2E). More generally, only a
third of NF-Y loci (clusters B, K, L, N, P, S,
U, V; n = 4061) (Fig. 3A) are associatedwith
active promoters, as defined by high levels
of di- and trimethylated H3K4, acetylated
H3K27 and H3K9, Pol II, and nucleosome
depletion (defined by a ‘‘valley’’ of low
enrichment of mono-methylated H3K4
at NF-Y summits and a FAIRE signal) (Fig.
3A,B). By comparison, essentially no sites
are located within nonmodified chroma-
tin regions, and only a few MYC sites are
locatedwithinweak enhancer-like regions
(low K4me1 signals; Supplemental Fig. 7).
A subset of NF-Y sites is located
at tissue-specific enhancers
Although NF-Y is typically described as
a proximal promoter factor, binding to
enhancers has been described, e.g., the 59
upstream regions of the MHC class II genes (Dorn et al. 1988) and
the intronic enhancer of the HOXB4 gene (Gilthorpe et al. 2002).
In this regard, all four enhancer chromatin states, as defined by
Ernst et al. (2011), are bound by NF-YB (Fig. 2C), totaling 25% of
NF-Y peaks in K562. From clustering analysis of histone modifi-
cations and Pol II, 12% of all NF-Y sites (clusters E, R, and T; n =
1525) have histone modification patterns typical of enhancers:
high H3K4me1, low H3K4me2/me3, low Pol II, and only a modest
overlap with RefSeq TSSs (Fig. 3A,B). This is also observed with
Figure 2. Annotation of NF-Y peaks to genomic features. (A) Kernel density estimate of the distribution
of the 59-CCAAT-39 and 59-ATTGG-39 sequences under NF-YA and NF-YB peaks in relation to the peak
summit centered at 0 bp. Only the position of the best matching CCAATmotif within 100 bp of the peak
summit is considered and plotted. (Solid and dashed lines) Raw and Gaussian smoothed data, re-
spectively. (B) Annotation of K562NF-YB sites to RefSeq gene features. (C ) As in B, except chromatin state
maps are used. (Prom) promoter; (enh) enhancer; (trxn) transcription. Numbering is from the chromatin
state maps of Ernst et al. (2011). (D) Frequency distribution of K562 NF-YB peak summits at RefSeq TSSs
showing a preferential location between 50 and 100 bp upstream of the TSS. (E ) Gaussian kernel
density estimate of the distribution of positive and negative strand 59-CCAAT-39 and 59-ATTGG-39 se-
quences at K562 NF-YB-bound RefSeq TSSs. Only the best motif per region is considered. Bandwidth is
equal to the standard deviation of the smoothing kernel. (Gray arrows) Direction of transcription.
Fleming et al.
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NF-Y sites in HeLa S3 (Supplemental Fig. 8). The apparent dis-
crepancy in theNF-Y sites in K562 designated as enhancer (25%vs.
12%) is likely due to our more conservative definition of enhancer
and wider region used for interpretation. Clusters E and R (Fig. 3A)
are exceptional in that they represent NF-Y sites located close to
(;2.5 kb), but not within regions of high enrichment for H3K27ac,
H3K9ac, H3K4me1/me2/me3 (i.e., strong actively transcribing
promoters), unlike all other clusters from the enhancer and pro-
moter groups, where NF-Y is directly within the domains enriched
for acetylation and methylation.
Figure 3. NF-YB bound loci reside within five epigenetic domains. (A) K-means clustering of K562 NF-YB loci based on the distribution of histone PTM,
RNA Pol II, NF-YB, and NF-YA ChIP-seq reads within a region spanning65 kbp from the summit of NF-YB peaks (centered at 0 bp). Clustering was carried
out on transformed, rank normalized read counts. Raw read count intensity is depicted in red. The interpretation and classification of clusters into
functional categories are shown at right. (B) NF-YB summits from clusters derived from A are annotated to genomic features: chromatin states, LTRs, dbTSS,
RefSeq promoters, and FAIRE-seq regions. The percentage of peak summits within each cluster overlapping a specific feature is indicated. Overlap with
LTRs is assayed within a window of6250 bp from the ends of the LTR feature. RefSeq promoters are considered within a window of2500:+500 bp from
the TSS. A direct overlap with FAIRE-seq regions and chromatin states is used. Long poly(A) purified RNA reads were counted within a window of6500 bp
about the NF-YB peak summit, and the median value of that cluster is shown (n = size of cluster in peaks).
Genome-wide analysis of NF-Y
Genome Research 1199
www.genome.org
 Cold Spring Harbor Laboratory Press on April 7, 2014 - Published by genome.cshlp.orgDownloaded from 
Interestingly, cell-type-specific NF-Y sites are enriched for
enhancers and are, on average, located further away from TSSs as
compared with NF-Y sites common to all cell types (Supplemental
Fig. 9A,B). GO analysis of cell type-specific NF-Y loci reveals cate-
gories enriched in individual cell types. NFkappaB cascade and reg-
ulation of IL12 is enriched in GM12878, a cell type in which
NFkappaB is constitutively active (Gubler et al. 1991; Wolf et al.
1991), and HeLa S3 shows enrichment for epidermis morpho-
genesis and establishment of tissue polarity, commonly associated
with cells of epithelial origin (Supplemental Fig. 4B).
Functional inactivation of NF-YA supports a transcriptional
role for NF-Y located distally to TSSs
The large number of NF-Y locations at distal enhancers that are
functional as defined by the histonemodification pattern (Fig. 2C)
and previous analysis of individual genes (Dorn et al. 1988;
Gilthorpe et al. 2002) strongly suggests that NF-Y binding to distal
locations can have functional consequences. To provide additional
evidence for this idea, we performed expression array analysis on
HeLa S3 cells depleted for NF-YA by lentiviral small hairpin RNA
(shRNA) (Supplemental Fig. 10A,B) and correlated these changes to
the location of NF-Y (Supplemental Figs. 10C, 11A,B). At a P-value
cutoff of 104, 84 genes are down-regulated and 252 genes are up-
regulated (Supplemental Fig. 10C) upon NF-YA knockdown. Of
these, only 11% (n = 9) and 39% (n = 98) have NF-Y bound to
their proximal promoters, respectively. The topmost differentially
down- and up-regulated genes both trend toward having a higher
percentage of their promoters occupied by NF-Y than non-
differentially regulated genes (Supplemental Fig. 11A). Of the 1059
NF-YA peaks inHeLa S3 locatedwithin 250 bp of a RefSeq TSS, only
5.2% are differentially regulated at a P-value of 104 (n = 55). The
low percentage of differentially regulated genes bound by NF-Y is
similar to that found with other TFs (Yang et al. 2006; Strub et al.
2011; Martynova et al. 2012) and could be exacerbated by the in-
complete functional inactivation of NF-Y.
We ranked NF-Y sites by the fold change in RNA expression of
the nearest associated gene upon NF-YA inactivation. Importantly,
for both promoters and distal regions, the topmost differentially
down- and up-regulated genes both trend towards having a higher
percentage of NF-Y occupancy than nondifferentially regulated
genes (Supplemental Fig. 11A). In addition, the most strongly
down-regulated genes have NF-Y sites that are much more distal
to the TSS, with the median distance being >10 kb; this prefer-
ence for distal sites is not true for MYC (Supplemental Fig. 11B).
This observation suggests the possibility that distal NF-Y sites
might be more important for differential regulation. Whatever
the relative importance of NF-Yat promoters and enhancers, our
results support the idea that NF-Y located at both promoters and
enhancers can be important for transcription of neighboring
genes.
LTRs are the most prevalent class of NF-Y sites in the human
genome
Of all NF-Y binding sites in K562, 40% directly overlap an LTR, the
promoter elements of endogenous retroviruses, making LTRs the
most prevalent class of NF-Y loci in the human genome (Fig. 4A).
NF-Y selectively associates with the MLT1 and LTR12 families of
LTRs (Fig. 4B,C). NF-Y does not bind to all LTR families, irrespective
of the presence of a CCAAT motif in the consensus sequence. The
R66 tandem repeat (which is related to LTR12B) (Benachenhou
et al. 2009a,b),MER51A andMER51E are also associatedwithNF-Y.
In general, there is no significant cell-type specificity in LTR
binding (Supplemental Fig. 12).
Most NF-Y bound sites at LTRs lack any detectable histone
modificationswithin 5 kbp of theNF-Ypeak summit (Figs. 3A,B, 4D,
clustersD and J) . TheseNF-Y loci appear to be inactive, yetmaintain
substantial NF-Yoccupancy. In contrast, a sizeable minority of LTRs
(27%K562; 20%GM12878) (Fig. 4D) are associatedwith high levels
of H3 acetylation and/or H3K4 methylation and appear to be
transcriptionally active. This minority class most likely represents
NF-Y-bound functional regulatory elements derived from trans-
posable repetitive elements and regulating endogenous genes.
LTRs function as promoter elements of endogenous retrovi-
ruses and they can act as regulatory elements for certain host genes
(Bourque 2009). NF-Y sites abound in viral LTRs (Graves et al. 1986;
Dutta et al. 1990; Faber and Sealy 1990; Greuel et al. 1990; Scheef
et al. 2002). The selectivity for the gamma-retrovirus LTR family,
and within it for certain members, likely reflects the presence of
CCAAT in the original viral LTRs. Thus, our results suggest a strong
genetic pressure on their genomic transduced copies to maintain
NF-Y binding. This is not unprecedented, as evidenced by the
preference of particular TFs for specific repetitive sequences
(Bourque et al. 2008; Kunarso et al. 2010). Genetic analysis of the
ERV-9/LTR12 element located 59 of the globin locus-control region
indicates a crucial role of the 14 CCAAT and GATA containing E3
repeats for expression of the b-globin locus (Yu et al. 2005; Pi et al.
2010). Despite this precedent, most NF-Y sites are associated with
heterochromatin-like domains and are apparently devoid of
any transcriptional signal. As the vast cohort of endogenous LTR
proviral sites are under strong control by the host organism and,
in most cases, actively repressed (Bourque 2009), we are tempted
to speculate that NF-Y plays a role in the repression of these LTRs
in somatic tissue and/or in their activation during embryogene-
sis, where many repetitive elements are demethylated and be-
come expressed (Maksakova et al. 2008).
NF-Y binds CCAATmotifs in nonmodified chromatin domains
in vivo, unlike most TFs
Themajority of NF-Y sites (n = 6169; 49%) are in two similar clusters
(D and J, i.e., LTR/nonmodified-chromatin class in Fig. 3A,B) that
display no positive or repressive histone modifications tested for,
negligible Pol II and polyA RNA, and overlap few open regulatory
regions (11%, 25%) and RefSeq TSSs (7%, 11%). An analysis of
MYC sites reveals the absence of binding at nonmodified chro-
matin sites (Supplemental Fig. 7). Interestingly, most of these loci
overlap LTRs, 58% and 82%, respectively (Fig. 3B). These NF-Y sites
are interesting, as most TFs are believed to not be able to bind to
their DNA motifs within closed, transcriptionally inactive chro-
matin domains.
To further explore this issue, we calculated the percentage of
motifs residingwithinNF-Ypeakswithin distinct chromatin states,
over a range of motif quality scores. Interestingly, and unlike other
TFs such as E2Fs and MYC, NF-Y is not excluded from any chro-
matin state assayed (Fig. 5A,B). At strong and weak promoters,
>80% of CCAATmotifs (scores >16) are occupied by NF-Y (Fig. 5A).
CCAAT motifs at enhancers and insulators are also well occupied
by NF-Y (30%–75%, respectively) (Fig. 5A), although the percent
occupancy is lower than at strong promoters, indicating that
binding to these genomic regions ismore selective.More generally,
CCAATmotifs situated within open chromatin regions, as defined
by FAIRE, are exceptionally well occupied to near-saturated levels
Fleming et al.
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Figure 4. NF-YB binds extensively to long terminal repeats. (A) The percentage of all K562 NF-YB peak summits that occupy the indicated feature. Core
and proximal promoters are defined as250:+50 bp and2500:+500 bp from the TSS of RefSeq promoters, respectively. (B) Mapping of ChIP-seq reads
from K562, GM12878, and HeLa S3 to Repbase consensus sequences showing an abundance of NF-Y ChIP-seq reads mapping to repetitive elements.
Ratios reflect the enrichment of reads in the NF-YB ChIP sample as compared with input. Only Repbase entries with a read ratio $5 are shown. Orange
shading indicates enriched repeats present in all cell lines. Green and red shading indicate the presence and absence, respectively, of a CCAATmotif match
at P-value < 104 in the consensus sequence. (C ) Frequency of overlap between NF-YB peak summits and the genomic locations of LTR families. Only LTR
elements that overlap at least one NF-YB summit in each cell line are shown. The two most highly overlapping repeat families are indicated, LTR12 and
MLTJ1. (D) Distribution of NF-YB bound LTRs from K562 and GM12878 at chromatin states. No chromatin state map is available for HeLa S3.
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byNF-Y, with 80% occupancy (Fig. 5A). Interestingly, many CCAAT
motifs within the nonmodified chromatin, PcG repressed and
transcription elongation states are occupied by NF-Y at a rate of
;20% (Fig. 5A).
To test whether the substantial occupation of CCAAT motifs
within nonmodified chromatin and repressed genomic contexts is
unique to NF-Y, we performed the same analysis on 22 additional
TFs, whose binding sites in K562 cells have been determined by
ENCODE. As expected, most TFs show high levels of motif occu-
pancy at nucleosome-depleted regulatory regions at high levels,
comparable to that of NF-Y (Fig. 5C; Supplemental Fig. 13). In con-
trast, GATA1 andGATA2, thought to be ‘‘pioneer’’ TFs (Magnani et al.
2011; Zaret and Carroll 2011), are highly selective and unable to
saturate their motifs that reside within these nucleosome-depleted
regulatory regions. However, most TFs lack the ability to occupy
even their highest quality motifs within nonmodified and re-
pressed chromatin states. For the 23 factors tested, only USF1,
MAFK, and NF-Y can bind to motifs in the context of nucleosomes
lacking some of the most common ‘‘positive’’ histone modifica-
tions or containing the repressive H3K27me3 mark.
Figure 5. NF-YB can occupy its motif in closed chromatin. (A) The percentage of genome-wide computationally discovered CCAAT motifs within each
chromatin state, FAIRE-seq regions or the entire genome, that directly overlap NF-YB K562 sites plotted as a function of CCAAT motif quality (right axes).
Also shown are the numbers of discovered CCAAT motifs as a function of quality (left axes). Numbering is derived from Ernst et al. (2011) and kept for
consistency. (B) Distribution of CCAAT motif quality scores under NF-YB K562 peaks, called at three different P-values, a random genomic background
sample set of 400 k 500-bp regions and K562 FAIRE-seq regions. (C ) Similar to A, except motifs of different TFs are plotted as a function of motif quality.
Only a subset of TFs is shown; see Supplemental Figure 13 for all TFs analyzed.
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By preventing accessibility to target sites, chromatin is a for-
midable barrier for binding by most TFs. This creates a dilemma as
to how cis-regulatory motifs can provide transcriptional compe-
tency if they cannot be accessed by their corresponding TFs. There
are a small number of ‘‘pioneer’’ factors that can efficiently bind to
their DNA motif located within nonmodified, closed chromatin.
Once bound, these pioneer TFs can recruit chromatin-modifying
activities to generate open chromatin for the subsequent binding
of partnering TFs (Magnani et al. 2011; Zaret and Carroll 2011).
NF-Y can associate with a CCAAT motif after nucleosome assembly
in vitro, and the NF-YB/NF-YC HFD dimer can physically interact
with H3/H4 in solution and on DNA (Caretti et al. 1999). Indeed,
NF-Y binding is not mutually exclusive with nucleosomes in vitro,
giving NF-Y the theoretical functional ability to interact efficiently
with chromatin-bound CCAAT motifs in vivo. NF-Y binds to a
sizeable number of sites either in functionally ‘‘hostile’’ environ-
ments or sites lacking all of the common positive histone modifi-
cations. Perhaps the structural features of the HFD heterodimer are
instrumental for this. We propose that NF-Y is a type of ‘‘pioneer’’
TF that retains histone-like features while possessing high-se-
quence specificity, with the ability to access itsmotif irrespective of
the chromatin state.
NF-Y extensively coassociates with FOS, typically at loci lacking
an AP-1 motif
Unexpectedly, we observe a remarkable coassociation of NF-Y and
FOS (Pearson = 0.74) that is only marginally lower than that ob-
served between the NF-Y subunits (Pearson = 0.77) (Fig. 6A). This
coassociation is observed over all chromatin states, cluster classes,
and genic features, with 45% of NF-Y sites directly overlapping
a FOS site and 39% of FOS sites directly overlapping an NF-Y site
(Fig. 6B). Similar results are observed in HeLa S3 cells, although the
overlap is slightly lower (26%and 16%, respectively). Interestingly,
NF-Y does not significantly coassociate with JUN (Pearson = 0.14),
a TF that forms heterodimers with FOS (Fig. 6A). NF-Yand FOS sites
are located just as close (<50 bp) as that observed between the NF-Y
subunits or between FOS and JUN (Fig. 6C). Interestingly, most
sites bound by NF-Yand FOS lack detectable AP-1 motifs (Fig. 6D),
with the notable exception being sites at LTR loci (see below). In
contrast, and as expected, most sites bound by FOS and JUN have
an AP-1 motif (Fig. 6D). A representative example of the interplay
is shown in Figure 6E.
NF-Y and FOS protein–protein interactions have not been
described, but the striking colocalization of these factors suggests
the possibility of a direct interaction in the context of chromatin.
Alternatively, the coassociation at genomic sites in vivomaynot be
due to a direct interaction between these factors. In this regard,
ChIP-seq analysis reveals that sites bound by JUN N-terminal ki-
nases ( JNKs) generally lack AP-1 motifs, but often contain CCAAT
motifs (Tiwari et al. 2012). Furthermore, NF-Y is necessary for the
JNK association with these genomic sites. We speculate that FOS,
together with another protein(s) such as JNK, binds to NF-Y at
CCATT motifs in the context of chromatin.
NF-Y coassociates with different TFs depending on genomic
context
Given the availability of 78 ChIP-seq data sets in K562 for chro-
matin associating factors involved in diverse functions, we ex-
plored combinatorial genomic interactions of these factors with
NF-Yon promoters and enhancers. On a pairwise basis, we observe
coassociation between NF-Y and 44 factors at promoters and 50
factors at enhancers (P < 1010, Supplemental Fig. 14A), consistent
with the general requirement for multiple TFs to stimulate tran-
scription in mammalian cells. Hierarchical clustering (Supple-
mental Fig. 14B), and analysis of higher order combinations of
factors (Supplemental Fig. 14C), reveals distinct groups of factors at
proximal promoters and enhancers. At promoters, the core group of
NF-Y coassociating factors includes FOS, CHD2, TBP, Pol II, CCNT2,
HMGB2, MYC, and E2F4/-6 (Supplemental Fig. 14B). A comparison
of promoters that are or are not boundbyNF-Y reveals that only FOS
and (to a lesser extent) CHD2 are specifically associated with NF-Y.
FOS associates with 59% of promoters bound by NF-Y, but only 8%
of promoters not bound by NF-Y. The other factors were common
promoter bound TFs (Supplemental Fig. 14C). At enhancers, NF-Y
forms awell-defined cluster consisting of FOS,USF1/2,MAX, CHD2,
and E2F4 (Supplemental Fig. 14B), a slightly different grouping
compared with promoters. FOS and USF1 are highly prevalent, be-
ing present, respectively, at 39% and 27% of NF-Y enhancers, and
were the most common 2-way overlap at 13% (Supplemental Fig.
14C). A summary of the interactions at promoters and enhancers is
shown in Figure 7.
The widespread partnership of NF-Y with a group of TFs (FOS,
MYC, and E2Fs) that control cellular proliferation and play im-
portant roles in cancer are consistent with the importance of NF-Y
for expression of growth-regulating genes. The close association of
the E2Fs and NF-Y is consistent with the high enrichment of their
motifs at promoters of genes overexpressed in tumors (Rhodes et al.
2005; Sinha et al. 2008; Goodarzi et al. 2009). In addition, apoptosis
mediated by overexpression of NF-Y is abolished in cells lacking
E2F1 (Gurtner et al. 2010). E2F4 is part of the DREAM complex
(Litovchick et al. 2007; Schmit et al. 2007), which binds to the CDE
motif, and cooperates with the CCAAT motif to negatively regulate
expression of G2/M-specific genes during the cell cycle (Muller and
Engeland 2010; Muller et al. 2012). CCAAT motif and CDE con-
taining G2/M genes are significantly overexpressed in a model of
stepwise transformation of primary fibroblasts (Tabach et al. 2005).
Essentially, all E box binding TFs present in ENCODE are sta-
tistically enriched at NF-Y locations (Supplemental Fig. 14A), sug-
gesting a pervasive partnership between CCAAT and E boxes. In-
terestingly, the number of MYC/NF-Y bound promoters exceeds
those with MAX/NF-Y, suggesting that either MYC heterodimerizes
with another E box binding partner, or that it binds in an E box-
independent manner, possibly directly to NF-Y (Izumi et al. 2001;
Ravasi et al. 2010).
At the LTR/nonmodified chromatin class, NF-Y extensively
colocalizes only with FOS, USF1, and to a lesser degree, USF2 and
SP1, although specific groupings occur upon clustering (Supple-
mental Fig. 15A). The chromatin at colocalized NF-Y/USF sites is
not acetylated, suggesting that USF1 and USF2, in the context of
binding with NF-Y, do not behave as barrier elements of acetylated
chromatin in intergenic regions that inhibit the spread of hetero-
chromatin (West et al. 2004; Huang et al. 2007; Li et al. 2011). It
should also be noted that cluster HL2 (n = 147; Supplemental Fig.
15A) is enriched for four members of the CTCF–cohesin insulator
complex (CTCF, CTCFL, RAD21, and SMC3) in direct proximity
with NF-Y, and a similar small cluster is also observed in the PcG
repressed class (data not shown). Interestingly, the NF-Y-bound
regions in the LTR/nonmodified chromatin class show a remark-
able paucity of known DNA motifs, with the exception of the
CCAATmotif and in K562, but not GM12878, the KLF4 motif (P =
1.6 3 1010; data not shown). De novo motif analysis of the same
NF-Y sites again reveals the CCAAT and KLF4 motifs as well as two
Genome-wide analysis of NF-Y
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unknown motifs (Supplemental Fig. 15B). As KLF4 can act as a
transcriptional activator or repressor (Turner andCrossley 1998; van
Vliet et al. 2000; Schuierer et al. 2001; Yoon and Yang 2004; Evans
et al. 2007; Oishi et al. 2008) and is expressed in K562 cells (Kalra
et al. 2011), it may cooperate with NF-Y to repress LTR elements.
NF-Y sites contain positionally biased TFs
To investigate whether there is a specific distance relationship
between NF-Y and coassociating factors, we plotted the distri-
bution of the relative position of the TATA element, E box, E2F,
Figure 6. NF-Y and FOS are closely coassociated at loci that lack JUN and the AP-1 motif. (A) Correlation between ChIP-seq read counts at NF-YB peak
summits, within a window of 6500 bp, between NF-YB and NF-YA, FOS, JUN, or MYC in K562 cells. (B) Values represent the percentage of peak
populations (left row) directly overlapping the peak population of a second factor (top column). All binding sites are called at a P-value < 109. FOS
(n = 14404); JUN (n = 18480); MYC (n = 13693); NF-YA (n = 4726); NF-YB (n = 12655). (C ) The number of ChIP-seq peaks at the indicated distance
between adjacent peak summits is plotted. All peaks were called at a 109 P-value threshold in K562. (D) The top 1000 K562 FOS ChIP-seq sites, as ranked
by site P-value, that directly overlap an NF-YB site (‘‘FOS+NF-YB’’) and the top 1000 that do not overlap an NF-YB site (105 P-value site list, ‘‘FOS-NF-YB’’)
are assayed for the distribution of the AP-1motif in relation to the FOS peak summit centered at 0 bp. Plotted is the Gaussian kernel density estimate of the
AP-1motif using a bandwidth of 0.5 of the standard deviation of the smoothing kernel. The top threemotifs discovered de novo from each FOS peak set, as
above, are depicted with the percentage of FOS peaks containing a match to that motif indicated. (E) Representative view of a locus on chromosome 3 of
the K562 ChIP-seq read counts from NF-YA, NF-YB, FOS, JUN, and MYC ChIPs, with an input control.
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and AP-1 motifs (termed ‘‘predicted’’) at NF-Y peaks in relation
to the position of the best-scoring CCAAT motif, while main-
taining strandedness. We then plotted the subset of motifs
(termed ‘‘verified’’) that were actually occupied in vivo by the
TF of interest. Remarkably, there is an AP-1 motif 10- to 11-bp
upstream of CCAAT, which corresponds to verified FOS target
sites (Fig. 8A). However, this positioning was only found at
NF-Y-bound LTRs, as sites with NF-Y and FOS generally do not
contain an AP-1 motif (Fig. 6D). The TATA element (+50), E box
(12/11) and E2F (+6/+7, +31, +55, and +72) motifs are also
highly positioned in a CCAAT orientation-specific manner
(Fig. 8B). The position of the TATA element is maintained in
TBP-bound locations at NF-Y sites. The E2F motif is unusual
in that multiple stereo alignments are present and only one,
the closest to CCAAT, is maintained at E2F6, but not at E2F4
occupied sites (Fig. 8B; data not shown). The positioning of
the E box is only maintained when MAX or USF1 but not MYC
loci are considered, suggesting that MYC, when associating
with NF-Y, is either not positioned or does not bind DNA
directly.
The USF1 observation is interesting because it is one of the
few factors that partners with NF-Y in the LTR/nonmodified
chromatin class and can bind its motif within a repressive nucle-
osomal structure. Perhaps the precise positioning may facilitate
the cooperation of NF-Y and USF1 to penetrate inactive, non-
modified chromatin domains.
Cooperativity mediated by precise spacing between NF-Y
and other TFs has been observed at MHC class II promoters, NF-
Y/ATF6 sites in ER-stress responsive promoters (Yoshida et al.
2000), and multiple CCAAT motifs in G2/M promoters (Salsi
et al. 2003). Our results greatly extend these findings of precise
spacing relationships with NF-Y with its most common TF
partners, notably those that play crucial roles in the control of
cell proliferation, cell cycle, and metabolism genes. In the vast
majority of NF-Y-bound promoters, where NF-Y synergizes with
neighboring TFs, it appears to be more of a promoter organizer
and facilitator of transcription than a strong activator per se.
Our results strongly suggest that cooperativity mediated by
precise spacing is a general mechanism
utilized by NF-Y to regulate transcrip-
tion of its target genes.
Conclusions
Our comprehensive analysis of NF-Y con-
firms many functions including its prev-
alence at proximal promoters, particu-
larly those of growth controlling genes, at
a much higher degree of precision and
completion. More interestingly, our anal-
yses uncover several novel and unex-
pected aspects of NF-Y function. In par-
ticular, NF-Y binds asymmetrically at its
target sites, plays an important role at
many tissue-specific enhancers, is capa-
ble of binding ‘‘closed’’ chromatin in-
cluding at LTRs, coassociates pervasively
with FOS but not other AP-1 factors, and
displays precise stereo positioning with
a restricted group of TFs involved in cel-
lular proliferation. Lastly, we note that
comprehensive bioinformatic analyses of
the type performed here have been done on relatively few TFs.
Similar analyses on other TFs whose target sites have been or will
be defined by ChIP-seq are likely to uncover new functional
properties and relationships of biological relevance.
Methods
Cell culture
K562, GM12878, and HeLa S3 were grown as per standard
ENCODE protocols (The ENCODE Project Consortium 2011)
and a detailed protocol is available at http://genome.ucsc.edu/
ENCODE/.
ENCODE data sets
ChIP-sequencing data sets for histone PTMs, TFs, and RNA-seq
for K562 and/or HeLa S3 cell lines were provided by ENCODE via
the UCSC Genome Browser and are described there and elsewhere
(The ENCODE Project Consortium 2011; http://genome.ucsc.edu/
ENCODE/). ChIP-seq data sets were mapped and peaks called as
described in the Supplemental Methods. RNA-seq data was pre-
pared by Helicos as long (>200 nt), poly(A)-enriched, cytosolic
RNA, and mapped using rSeq ( Jiang and Wong 2008, 2009). Chro-
matin state maps and the associated numbering are from ENCODE
and are detailed at http://genome.ucsc.edu/ENCODE/ and in Ernst
et al. (2011). The chromatin state ‘‘heterochromatin’’ was renamed to
‘‘non-modified-chromatin.’’
Lentiviral knockdown and gene expression arrays
Scrambled control (shSCM) and NF-YA pLKO.1-shRNAs were
designed by Sigma-Aldrich. The puromycin resistance cassette was
replaced with an EGFP cassette. Viral production and transduction
were carried out as previously described (Benatti et al. 2011). HeLa
S3 cells were transduced with shSCM (scrambled control) or shNF-
YA viral supernatants, in triplicate, and cells were collected after 48
h of incubation. The distribution of cells within the cell cycle was
checked via FACS as previously described (Benatti et al. 2011).
Knockdown efficiency was assayed by PCR on cDNA to known
Figure 7. NF-Y coassociates with many factors at promoters and enhancers. Illustration of the factors
that significantly associate with NF-YB-bound strong promoters and enhancers. Only those factors that
satisfy the following criteria are shown: greater than the median fold enrichment with respect to NF-YB-
nonbound regions (enrichment indicated by circle size); greater than the median value of percent
occupancy of NF-YB-bound regions (percentage occupied indicated by color); significantly coassociate
with NF-Y (gray box, see Supplemental Fig. 14A). Factors enclosed within a yellow box are, additionally,
the subset of factors that cluster with NF-YA and NF-YB (see Supplemental Fig. 14B). A black arrow
indicates the start of a transcribed region. Two vertical slashes are used to represent being distal to
a promoter area.
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NF-YA target genes and by Western Blot on whole-cell protein ex-
tracts using anti-NF-YA and anti-actin antibodies. For arrays, total
RNA was prepared by TRIzol extraction and Qiagen RNeasy kit pu-
rification, converted to biotinylated aRNA, and hybridized to U133
Plus 2.0 GeneChip expression arrays using the 39 IVT Express Kit
(Affymetrix) following the manufacturer’s protocol. Arrays were
RMA normalized (Irizarry et al. 2003), gene expression levels cal-
culated, differential expression determined, and probes annotated
using the following R packages from the Bioconductor project: affy
(Gautier et al. 2004), limma (Smyth 2004), and annaffy (http://
www.bioconductor.org/packages/devel/bioc/html/annaffy.html).
Annotation of peaks to gene features, GO analysis (GREAT/IPA)
Genomic locations of peak summits (where summit is the local
maxima in read counts) were submitted to the annotation tool
GREAT (McLean et al. 2010) using the following parameters:
whole-genome background set, basal plus extension, proximal
upstream, 5 kbp; proximal downstream, 1 kbp; distal, 1 mbp; or
whole-genome background set, basal, proximal upstream, 5 kbp;
proximal downstream, 1 kbp. Molecular
signaling pathways were visualized us-
ing IPA (Ingenuity Systems: http://www.
ingenuity.com) where a gray-shaded node
represents a K562 NF-YB binding site lo-
cated within the putative regulatory re-
gion, as defined by GREAT, of that mole-
cule. Peak summits were annotated to
genomic features using in-house scripts.
Motif stereo-positioning
NF-YB summit locations from K562 were
scanned using Pscan (Zambelli et al. 2009)
for matches to the NF-Y matrix in the
JASPAR_CORE_2009 database (MA0060.1)
(Portales-Casamar et al. 2010). For NF-Y
loci with the best matrix match on the
positive strand, the first C (of CCAAT) of
the best match was set to 0 bp. Genomic
sequences 675 bp from the motifs were
retrieved and scanned with Pscan using
the collection of matrices in the JASPAR_
CORE_2009 database (Portales-Casamar
et al. 2010). For each JASPAR matrix,
only regions containing a best matrix
match >0.8 (computed as described in
Zambelli et al. 2009) were considered
for further analyses. This population
was deemed ‘‘predicted.’’ For each ‘‘pre-
dicted’’ population, the subpopulation
of regions that overlapped the relevant
TF ChIP-seq peak data set were deemed
‘‘ChIP verified.’’ The frequency of the best
motif occurrences for each motif matrix
at each base pair from the CCAAT motif
was determined for each population and
plotted as the percentage of motifs.
Histone modifications and chromatin-
associated factor clustering
Density arrays at NF-YB peak summits
spanning either 65 kbp or 6500 bp rep-
resenting ChIP-seq read counts of histone
PTMs (H3K79me2, H3K4me3, H3K27me3, H3K4me1, H4K20me1,
H3K36me3, H3K4me2, H3K9ac, H3K9me1, H3K27ac), NF-YA, NF-
YB, and RNA Pol II or NF-YA, NF-YB, and 78 chromatin-associated
factors (see Supplemental Fig. 15A for the full list) with appropriate
input samples, were computed using the ranked based correlation
method of seqMINER v1.2 (Ye et al. 2011). Clustering was carried
out using the following parameters: T = 10, K-means. Clusters from
three to 50 were considered. Non-normalized raw read counts are
depicted in Figure 3A and Supplemental Figures 7, 8, and 15A.
Mapping to repeats
Bowtie (Langmead et al. 2009) was used to map the NF-YB and
input ChIP-seq data sets to a reference genome composed
of Repbase v15.08 ( Jurka et al. 2005) entries—simple.ref, humrep.
ref, humsub.ref, and pseudo.ref—allowing #2 mismatches per
read, and reads with >1 alignment had one alignment selected at
random. Read counts for each Repbase entry were tallied and the
ChIP:input ratio calculated. Individual consensus sequences of
repeat elements were scored for the presence or absence of the
Figure 8. Motif pairings with the CCAATmotif are stereo positioned. (A) The percentage of NF-Y sites
that have an AP-1 motif at the specified distance from the best scoring CCAAT motif centered at 0 bp.
NF-YB peaks overlapping LTRs are categorized as ‘‘predicted,’’ while the subset of NF-YB sites over-
lapping the respective ChIP-seq sites of FOS are categorized as ‘‘verified.’’ The negative strand plots are
near identical mirror images of the positive strand plots and are not shown. (B) Similar to A, except that
all genomic regions are considered. The percentage of NF-YB peaks that have a TATA element (TBP),
E box (MYC,MAX, USF1), and E2Fmotif (E2F6) are plotted. All NF-Y peaks are categorized as ‘‘predicted,’’
while those NF-Y peaks overlapping the respective ChIP-seq peaks of the other TF are categorized as
‘‘verified.’’ Only the top 500 peaks in each category are plotted.
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CCAAT motif using the matrix derived from this study and FIMO
(Grant et al. 2011), with matches called at a significance P-value
threshold of 104.
Hierarchical clustering of binding events to promoters
and enhancers
Regions considered promoters and enhancers were taken from the
K562 chromatin state maps of Ernst et al. (2011). Regions were
considered ‘‘bound’’ if an NF-YB peak summit directly overlapped
the region. Regionswere considered ‘‘nonbound’’ if noNF-YB peak
overlapped the region of interest and the region had <1.53 the
normalized fold-over-input ChIP-seq enrichment. At all NF-YB
bound or NF-YB nonbound regions, chromatin associated factors
were scored as present (1) or absent (0) based on directly overlap-
ping peak summits. The R packages pvclust (Suzuki and Shimodaira
2006) and snow (http://cran.r-project.org/web/packages/snow/)
were used to cluster the matrices and to calculate P-values us-
ing multiscale bootstrap resampling. Parameters were: method.
dist=’’binary’’, method.hclust=’’ward’’, nboot=10000. Red and
blue numbers in plots indicate the approximately unbiased (AU)
P-values and the bootstrap probability (BP), respectively, as de-
tailed in Suzuki and Shimodaira (2006).
Statistical test of TF coassociation with NF-YB
NF-YB-bound regions were as above. We assessed promoters or
enhancers occupied by NF-YB for individual co-occupancy of 78
transcriptional regulators. The significance of the overlap was
tested by a 2 3 2 contingency table using Fisher’s exact test and
calculated (Carlson et al. 2009), and P-values <109 were deemed
significant.
Data access
Microarray gene expression data from this study have been sub-
mitted to the NCBI Gene Expression Omnibus (GEO; http://
www.ncbi.nlm.nih.gov/geo/) under accession number GSE40215.
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